• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

撒哈拉以南非洲消除疟疾前环境下,影响常规监测系统中抗疟药物耐药性早期预警系统整合的因素。

Factors affecting integration of an early warning system for antimalarial drug resistance within a routine surveillance system in a pre-elimination setting in Sub-Saharan Africa.

作者信息

Kagoro Frank M, Allen Elizabeth, Raman Jaishree, Mabuza Aaron, Magagula Ray, Kok Gerdalize, Malatje Gillian, Guerin Philippe J, Dhorda Mehul, Maude Richard J, Barnes Karen I

机构信息

Collaborating Centre for Optimising Antimalarial Therapy (CCOAT), Division of Clinical Pharmacology, Department of Medicine, University of Cape Town (UCT), Cape Town, South Africa.

Mahidol Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

出版信息

PLoS One. 2025 Jun 3;20(6):e0305885. doi: 10.1371/journal.pone.0305885. eCollection 2025.

DOI:10.1371/journal.pone.0305885
PMID:40460097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12132925/
Abstract

To address the current threat of antimalarial resistance, countries need innovative solutions for timely and informed decision-making. Integrating molecular surveillance for drug-resistant malaria into routine malaria surveillance in pre-elimination contexts offers a potential early warning mechanism for further investigation and response. However, there is limited evidence on what influences the performance of such a system in resource-limited settings. From March 2018 to February 2020, a sequential mixed-methods study was conducted in primary healthcare facilities in a South African pre-elimination setting to explore factors influencing the flow, quality and linkage of malaria case notification and molecular resistance marker data. Using a process-oriented framework, we undertook monthly and quarterly data linkage and consistency analyses at different levels of the health system, as well as a survey, focus group discussions and interviews to identify potential barriers to, and enhancers of, the roll-out and uptake of this integrated information system. Over two years, 4,787 confirmed malaria cases were notified from 42 primary healthcare facilities in the Nkomazi sub-district, Mpumalanga, South Africa. Of the notified cases, 78.5% (n = 3,758) were investigated, and 55.1% (n = 2,636) were successfully linked to their Plasmodium falciparum molecular resistance marker profiles. Five tangible processes-malaria case detection and notification, sample collection, case investigation, analysis and reporting-were identified within the process-oriented logic model. Workload, training, ease of use, supervision, leadership, and resources were recognized as cross-cutting influencers affecting the program's performance. Approaching malaria elimination, linking molecular markers of antimalarial resistance to routine malaria surveillance is feasible. However, cross-cutting barriers inherent in the healthcare system can influence its success in a resource-limited setting.

摘要

为应对当前抗疟药物耐药性的威胁,各国需要创新解决方案,以便及时做出明智决策。在疟疾消除前期背景下,将耐药性疟疾的分子监测纳入常规疟疾监测,可为进一步调查和应对提供潜在的早期预警机制。然而,关于在资源有限的环境中影响此类系统性能的因素,证据有限。2018年3月至2020年2月,在南非一个疟疾消除前期地区的基层医疗机构开展了一项序贯混合方法研究,以探讨影响疟疾病例通报和分子耐药标记数据的流程、质量及关联的因素。我们采用面向过程的框架,在卫生系统的不同层面进行月度和季度的数据关联及一致性分析,同时开展一项调查、焦点小组讨论和访谈,以确定推广和采用这一综合信息系统的潜在障碍及促进因素。在两年多的时间里,南非姆普马兰加省恩科马齐分区的42家基层医疗机构通报了4787例确诊疟疾病例。在通报的病例中,78.5%(n = 3758)接受了调查,55.1%(n = 2636)成功与其恶性疟原虫分子耐药标记谱相关联。在面向过程的逻辑模型中确定了五个具体过程——疟疾病例检测与通报、样本采集、病例调查、分析和报告。工作量、培训、易用性、监督、领导力和资源被认为是影响该项目绩效的贯穿各领域的因素。在接近疟疾消除阶段,将抗疟药物耐药性的分子标记与常规疟疾监测相联系是可行的。然而,卫生系统中固有的贯穿各领域的障碍可能会影响其在资源有限环境中的成功实施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9448/12132925/5a4106c08586/pone.0305885.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9448/12132925/bce3bdfde69a/pone.0305885.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9448/12132925/580b0b5be71e/pone.0305885.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9448/12132925/5a4106c08586/pone.0305885.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9448/12132925/bce3bdfde69a/pone.0305885.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9448/12132925/580b0b5be71e/pone.0305885.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9448/12132925/5a4106c08586/pone.0305885.g003.jpg

相似文献

1
Factors affecting integration of an early warning system for antimalarial drug resistance within a routine surveillance system in a pre-elimination setting in Sub-Saharan Africa.撒哈拉以南非洲消除疟疾前环境下,影响常规监测系统中抗疟药物耐药性早期预警系统整合的因素。
PLoS One. 2025 Jun 3;20(6):e0305885. doi: 10.1371/journal.pone.0305885. eCollection 2025.
2
Making data map-worthy-enhancing routine malaria data to support surveillance and mapping of Plasmodium falciparum anti-malarial resistance in a pre-elimination sub-Saharan African setting: a molecular and spatiotemporal epidemiology study.使数据具有制图价值——增强常规疟疾数据,以支持在撒哈拉以南非洲消除前地区监测和绘制恶性疟原虫抗疟药耐药性的地图:一项分子和时空流行病学研究。
Malar J. 2022 Jun 29;21(1):207. doi: 10.1186/s12936-022-04224-4.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Monitoring parasite diversity for malaria elimination in sub-Saharan Africa.监测撒哈拉以南非洲消除疟疾的寄生虫多样性。
Science. 2014 Sep 12;345(6202):1297-8. doi: 10.1126/science.1259423.
5
Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001-2018).在南非姆普马兰加省使用青蒿素为基础的联合疗法 18 年后,尽管青蒿素耐药性标志物 kelch13 缺失,但对青蒿琥酯耐药性分子标志物 lumefantrine 却出现了强烈的选择。(2001-2018 年)
Malar J. 2019 Aug 22;18(1):280. doi: 10.1186/s12936-019-2911-y.
6
Deployment and utilization of next-generation sequencing of Plasmodium falciparum to guide anti-malarial drug policy decisions in sub-Saharan Africa: opportunities and challenges.在撒哈拉以南非洲地区部署和利用恶性疟原虫新一代测序技术以指导抗疟药物决策:机遇与挑战。
Malar J. 2019 Sep 3;18(1):267. doi: 10.1186/s12936-019-2853-4.
7
Antigenic strain diversity predicts different biogeographic patterns of maintenance and decline of antimalarial drug resistance.抗原株多样性预测了抗疟药物耐药性维持和下降的不同生物地理模式。
Elife. 2024 Feb 16;12:RP90888. doi: 10.7554/eLife.90888.
8
Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of Damocles in the path toward malaria elimination.恶性疟原虫对青蒿素联合疗法的耐药性:疟疾消除之路上的达摩克利斯之剑。
Parasite. 2018;25:24. doi: 10.1051/parasite/2018021. Epub 2018 Apr 20.
9
Variation in Calculating and Reporting Antimalarial Efficacy against Plasmodium falciparum in Sub-Saharan Africa: A Systematic Review of Published Reports.撒哈拉以南非洲地区抗疟功效计算和报告的差异:已发表报告的系统评价。
Am J Trop Med Hyg. 2021 Mar 15;104(5):1820-1829. doi: 10.4269/ajtmh.20-1481.
10
Malaria Surveillance - United States, 2015.疟疾监测 - 美国,2015 年。
MMWR Surveill Summ. 2018 May 4;67(7):1-28. doi: 10.15585/mmwr.ss6707a1.

本文引用的文献

1
Artemisinin resistance-associated gene mutations in Plasmodium falciparum: A case study of severe malaria from Mozambique.疟原虫青蒿素耐药相关基因突变:来自莫桑比克严重疟疾的案例研究。
Travel Med Infect Dis. 2024 Jan-Feb;57:102684. doi: 10.1016/j.tmaid.2023.102684. Epub 2023 Dec 29.
2
Identification of the PfK13 mutations R561H and P441L in the Democratic Republic of Congo.鉴定刚果民主共和国 PfK13 突变株 R561H 和 P441L。
Int J Infect Dis. 2024 Feb;139:41-49. doi: 10.1016/j.ijid.2023.11.026. Epub 2023 Nov 26.
3
Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia.
在埃塞俄比亚已经出现了对青蒿素具有抗药性的疟原虫和诊断方法。
Nat Microbiol. 2023 Oct;8(10):1911-1919. doi: 10.1038/s41564-023-01461-4. Epub 2023 Aug 28.
4
Unlocking the power of molecular and genomics tools to enhance cholera surveillance in Africa.释放分子和基因组学工具的力量以加强非洲霍乱监测。
Nat Med. 2023 Oct;29(10):2387-2388. doi: 10.1038/s41591-023-02492-4.
5
Stakeholder's perception of the health information system performance in Burkina Faso.利益相关者对布基纳法索卫生信息系统绩效的看法。
Pan Afr Med J. 2023 Mar 31;44:155. doi: 10.11604/pamj.2023.44.155.35294. eCollection 2023.
6
A pan-African pathogen genomics data sharing platform to support disease outbreaks.一个支持疾病暴发应对的泛非病原体基因组学数据共享平台。
Nat Med. 2023 May;29(5):1052-1055. doi: 10.1038/s41591-023-02266-y.
7
Making data map-worthy-enhancing routine malaria data to support surveillance and mapping of Plasmodium falciparum anti-malarial resistance in a pre-elimination sub-Saharan African setting: a molecular and spatiotemporal epidemiology study.使数据具有制图价值——增强常规疟疾数据,以支持在撒哈拉以南非洲消除前地区监测和绘制恶性疟原虫抗疟药耐药性的地图:一项分子和时空流行病学研究。
Malar J. 2022 Jun 29;21(1):207. doi: 10.1186/s12936-022-04224-4.
8
A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance.制定和评估复杂干预措施的新框架:对医学研究理事会指南的更新。
BMJ. 2021 Sep 30;374:n2061. doi: 10.1136/bmj.n2061.
9
Evidence of Artemisinin-Resistant Malaria in Africa.非洲出现青蒿素抗药性疟疾。
N Engl J Med. 2021 Sep 23;385(13):1163-1171. doi: 10.1056/NEJMoa2101746.
10
Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study.在卢旺达,恶性疟原虫kelch13 R561H 基因型与寄生虫清除延迟的关联:一项开放标签、单臂、多中心、治疗效果研究。
Lancet Infect Dis. 2021 Aug;21(8):1120-1128. doi: 10.1016/S1473-3099(21)00142-0. Epub 2021 Apr 14.